Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer

Zdroj: clincancerres.aacrjournals

Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer

Conclusions:
Dual inhibition of STAT3–NF-κB by Nexrutine may overcome problems associated with inhibition of either pathway. Clin Cancer Res; 20(5); 1259–73. ©2014 AACR.


Enhanced by Zemanta

Populární příspěvky z tohoto blogu

Synoviální sarkom

Implatabilní port

Paraneoplázie